Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. It serves orthopaedic, neuromolecular, pain, and interventional radiological surgeons. The company was founded in 2013 and is headquartered in Toronto, Canada.…
Aurora Spine Announces Publication of REFINE Study's 12-Month Results in the International Journal of Spine Surgery
Aurora Spine (CVE: ASG) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 0.0800 CAD on 19 November 2026, down 72.4% over 52 weeks. Its 52-week range is 0.0700 CAD to 0.3250 CAD: the price is 75.4% below the high and 14.3% above the low.
Its market capitalisation is 6.25M CAD.
Aurora Spine reports return on equity of -19.2%, an operating margin of -5.8% and revenue down 18.7% year over year.
Its debt exceeds its cash by 3.12M USD, a debt-to-equity ratio of 0.93. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. The next earnings report is expected on 23 November 2026.